Efficacy of a New Delivery System for Beta-hydroxy-beta-methylbutyrate
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The proposed study will test efficacy of HMB in free acid gel to decrease muscle damage, diminish inflammatory response, and improve muscle strength recovery following an acute exercise stress. HMB in a free acid gel or in CaHMB capsule form will be administered as either a single dose before a bout of acute exercise or in multiple doses (one before and three daily doses for the 4 days following the acute exercise). We hypothesize that HMB in free acid gel will result in less muscle damage, diminished inflammatory response, and improved muscle strength recovery than either a placebo or CaHMB treatment following a bout of acute eccentric exercise. Our endpoints will include measurements of: (1) markers for muscle damage (CPK and LDH); (2) indicators of inflammation (CRP, TNF-α, IL-6, IL-1ra and IL-18); and (3) muscle strength recovery and soreness.
Key facts
- Study ID
- NCT01150526
- Run by
- Metabolic Technologies Inc.
- People needed
- 41
- Starts
- 2010-10-01
- Expected to finish
- 2012-07-01
- Last updated by the study team
- 2012-07-18
Who can join
Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Must live within 50 miles of Ames, Iowa
- Free of cardiac, liver, pulmonary, and kidney disease
- Free of chronic inflammatory disease including rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, and psoriasis
- Free diabetes mellitus
- Not classified as morbidly obese (BMI must be less than 40)
- Free of cardiac, liver, pulmonary, and kidney disease
- No other serious medical illness
- Normal menstrual cycle and not pregnant or lactating
- Able to consume supplements and perform required exercise testing
You may not qualify if…
- Live more than 50 miles from Ames, Iowa
- Presence of cardiac, liver, pulmonary, and kidney disease
- Presence of chronic inflammatory disease including rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, and psoriasis
- Diabetes mellitus
- Classified as morbidly obese (BMI is greater than 40)
- No other serious medical illness
- Abnormal menstrual cycle, pregnant or lactating
- Not able to consume supplements and perform required exercise testing
Where it is running
- Iowa State University — Ames, Iowa, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.